Organization Program of DiabEtes INsulIN ManaGement

• Status: Unknown status
• Trial end date: 2012-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Diabetes is a common, costly condition associated with significant morbidity and mortality. Diabetes self-management education, the process of teaching individuals to manage their diabetes, has been considered an important part. The intensive education has the capacity to deliver effective interventions to a large number of people. The investigators may be able to redirect our efforts to diabetes care and education strategies that will have a positive impact on the optimization of glycemic control and the prevention of long-term complications of diabetes, reducing the subsequent human and health care costs.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chinese Diabetes Society
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Written Informed Consent obtained before any trial-related activities Type 2 DM subjects;

• Age > 18 years old,male or female;

• Continuous treated with two or more oral antidiabetic drugs (OADs) for the last 3 months,and the current HbA1c>7.5%;

• Cooperative with structured management;

Exclusion Criteria:

• Subjects with type 1 diabetes;

• Gestational diabetes mellitus and other specific types DM;

• Those who are unwilling to sign in ICF;

• Subjects with repeated hypoglycemia;

• Subjects with BMI>30kg/m2;

• Impaired liver function,defined as alanine aminotransferase (ALAT)>= 2.5 or alkaline phosphatase (ALP)>= 2 times upper referenced limit times upper normal limit;

• Females of childbearing age who are pregnant, breast-feeding or have the intention of becoming pregnant or not using adequate contraceptive methods throughout the trial (adequate contraceptive measures as required by local law or practice);

• Mental incapacity, unwillingness, or language barrier precluding adequate understanding or cooperation;

• Any other clinically significant condition or major systemic diseases, including serious coronary heart disease, cardiovascular disease, myocardial infarction within the past 12 months; severe neurology or psychology or psychiatric diseases; serious infection; actively disseminated intravascular coagulation;

• Malignant neoplastic diseases (except carcinoma in situ);

• Current addiction to alcohol or other addictive substances;